Glucose-regulated Protein 78 Is an Intracellular Antiviral Factor against Hepatitis B Virus

Yan Ma, Jun Yu, Henry Lik‐Yuen Chan, Yangchao Chen, Hua Wang, Ying Chen, Chu‐yan Chan, Minnie Y.y. Go, Sau‐Na Tsai, Sai Ming Ngai, Ka‐Fai To, Joanna H.m. Tong, Qing‐Yu He, Joseph J.�y. Sung, Hsiang‐Fu Kung, Christopher H.k. Cheng, Ming‐Liang HeMolecular 2009 · DOI

Abstract

Hepatitis B virus (HBV) infection is a global public health problem that plays a crucial role in the pathogenesis of chronic hepatitis, cirrhosis, and hepatocellular carcinoma. However, the pathogenesis of HBV infection and the mechanisms of host-virus interactions are still elusive. In this study, two-dimensional gel electrophoresis and mass spectrometry-based comparative proteomics were applied to analyze the host response to HBV using an inducible HBV-producing cell line, HepAD38. Twenty-three proteins were identified as differentially expressed with glucose-regulated protein 78 (GRP78) as one of the most significantly up-regulated proteins induced by HBV replication. This induction was further confirmed in both HepAD38 and HepG2 cells transfected with HBV-producing plasmids by real time RT-PCR and Western blotting as well as in HBV-infected human liver biopsies by immunohistochemistry. Knockdown of GRP78 expression by RNA interference resulted in a significant increase of both intracellular and extracellular HBV virions in the transient HBV-producing HepG2 cells concomitant with enhanced levels of hepatitis B surface antigen and e antigen in the culture medium. Conversely overexpression of GRP78 in HepG2 cells led to HBV suppression concomitant with induction of the positive regulatory circuit of GRP78 and interferon-beta1 (IFN-beta1). In this connection, the IFN-beta1-mediated 2',5'-oligoadenylate synthetase and RNase L signaling pathway was noted to be activated in GRP78-overexpressing HepG2 cells. Moreover GRP78 was significantly down-regulated in the livers of chronic hepatitis B patients after effective anti-HBV treatment (p = 0.019) as compared with their counterpart pretreatment liver biopsies. In conclusion, the present study demonstrates for the first time that GRP78 functions as an endogenous anti-HBV factor via the IFN-beta1-2',5'-oligoadenylate synthetase-RNase L pathway in hepatocytes. Induction of hepatic GRP78 may provide a novel therapeutic approach in treating HBV infection.
BibTeX
@inproceedings{ma2009glucose,
  author = {Yan Ma and Jun Yu and Henry Lik‐Yuen Chan and Yangchao Chen and Hua Wang and Ying Chen and Chu‐yan Chan and Minnie Y.Y. Go and Sau‐Na Tsai and Sai Ming Ngai and Ka‐Fai To and Joanna H.M. Tong and Qing‐Yu He and Joseph J.�Y. Sung and Hsiang‐Fu Kung and Christopher H.K. Cheng and Ming‐Liang He},
  title = {{Glucose-regulated Protein 78 Is an Intracellular Antiviral Factor against Hepatitis B Virus}},
  booktitle = {Molecular},
  year = {2009},
  doi = {10.1074/mcp.m900180-mcp200},
}

Loading related content...

Figure